Ceribell (CBLL) Cash & Equivalents (2023 - 2026)

Ceribell (CBLL) has reported Cash & Equivalents for 4 consecutive years, with $32.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 18.63% year-over-year to $32.7 million; the trailing twelve-month figure through Jun 2026 stood at $32.7 million (down 18.63% YoY), and the FY2025 full-year result was $40.5 million, down 79.18% from the prior year.
• Cash & Equivalents fell to $32.7 million in Q2 2026 per CBLL's latest filing, from $45.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $194.4 million in Q4 2024 and bottomed at $14.1 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $64.3 million across 4 years, with a median of $40.1 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 463.47% in 2024, then sank 79.18% in 2025.
• Over 4 years, Cash & Equivalents stood at $34.5 million in 2023, then surged by 463.47% to $194.4 million in 2024, then tumbled by 79.18% to $40.5 million in 2025, then dropped by 19.3% to $32.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $32.7 million, $45.3 million, and $40.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.